Nevertheless, our current findings offer compelling evidence that quantifying erythrocyte accumulation through glycophorin C staining, may serve as a marker for the evolution of atherosclerosis towards a plaque with a ‘vulnerable’ phenotype. This evidence concerns the gene GYPC and atherosclerosis.